/
Shutterstock 1954581052
Complement Research Solutions Across the Full Cascade

Biomedica supports complement research from sample stabilization to functional pathway analysis and biomarker detection. Our portfolio includes stabilizing solutions, complement activators, purified proteins, depleted sera, antibodies, ELISA assays, multiplex panels, standards, and assay development reagents.

 

Please note: Not all products are available in all Biomedica subsidiaries.

Reliable complement analysis starts with controlled sample handling and appropriate reference materials. Biomedica offers tools to help preserve complement activation status, reduce pre-analytical variability, and support robust assay setup:

  • Specimen stabilizing solution for serum and plasma
  • Human complement standards and reference materials
  • Normal human serum complement
  • Complement-depleted sera for controls and assay setup

Biomedica provides reagents for investigating complement activation, regulation, depletion, reconstitution, and pathway-specific mechanisms across the classical, alternative and lectin pathway:
 

  • Complement activators (Cobra venom factor, Heat-aggregated gamma globulin)
  • Purified complement proteins and complexes
  • Complement activation fragments
  • Complement regulatory proteins
  • Component-depleted sera
  • Reagents for animal-compatible C3 activity detection
  • Proteins and peptides for innate immunity and complement research

For quantitative and target-specific analysis, Biomedica offers single-marker immunoassays, multiplex panels, and antibodies for measuring complement activation, pathway components, regulators, and terminal pathway activity:

  • ELISA assays for single-marker quantification
  • Multiplex panels for parallel complement marker analysis
  • Monoclonal and polyclonal antibodies
  • Biotin-labeled antibodies
  • Mouse-specific antibodies for preclinical research
  • Antibodies for Western blot, immunofluorescence, flow cytometry, and assay development
  • Bulk formats and customized antibody formulations on request
12/11/2026